AGAPE ATP CORPORATION Increase (Decrease) in Income Taxes Payable
AGAPE ATP CORPORATION (ATPC) reported Increase (Decrease) in Income Taxes Payable of -$3.57 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-04-13
- AGAPE ATP CORPORATION increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was $1.03K.
- AGAPE ATP CORPORATION increase (decrease) in income taxes payable for the quarter ending 2024-12-31 was -$8.87K, a 10790.36% decline year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in income taxes payable for the quarter ending 2024-09-30 was -$3.02K.
- AGAPE ATP CORPORATION increase (decrease) in income taxes payable for the quarter ending 2024-06-30 was $9.61K.
- AGAPE ATP CORPORATION increase (decrease) in income taxes payable for fiscal 2025 was -$3.57K, a 182.33% decline from fiscal 2024.
- AGAPE ATP CORPORATION increase (decrease) in income taxes payable for fiscal 2024 was $4.34K.
- AGAPE ATP CORPORATION increase (decrease) in income taxes payable for fiscal 2023 was -$10.59K, a 251.86% decline from fiscal 2022.
- AGAPE ATP CORPORATION increase (decrease) in income taxes payable for fiscal 2022 was $6.97K, a 74.87% increase from fiscal 2021.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$3.57K 10-K · filed 2026-04-13 | ||
| 2025-09-30 | -$4.60K 10-Q · filed 2025-11-13 | |||
| 2024-12-31 | -$8.87K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$11.89K derived: sum of 2 quarters · filed 2026-04-13 | -$2.29K derived: sum of 3 quarters · filed 2026-04-13 | $4.34K 10-K · filed 2026-04-13 |
| 2024-09-30 | -$3.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $6.59K derived: sum of 2 quarters · filed 2025-11-13 | $13.21K 10-Q · filed 2025-11-13 | $13.30K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $9.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $16.23K 10-Q · filed 2025-08-13 | $16.31K derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | $6.63K 10-Q · filed 2025-05-15 | $6.71K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $83.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$10.59K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$10.67K 10-Q · filed 2024-11-14 | |||
| 2022-12-31 | $6.11K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.71K derived: sum of 2 quarters · filed 2024-04-01 | $6.64K derived: sum of 3 quarters · filed 2024-04-01 | $6.97K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$4.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $531.00 derived: sum of 2 quarters · filed 2023-11-14 | $864.00 10-Q · filed 2023-11-14 | -$21.34K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $4.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $5.26K 10-Q · filed 2023-08-14 | -$16.94K derived: sum of 3 quarters · filed 2023-08-14 | -$27.63K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $333.00 10-Q · filed 2023-05-15 | -$21.87K derived: sum of 2 quarters · filed 2023-05-15 | -$32.56K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$22.20K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$32.89K derived: sum of 2 quarters · filed 2023-03-31 | $3.99K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$10.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $26.19K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $36.88K 10-Q · filed 2022-08-11 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $5.33K derived: sum of 3 quarters · filed 2021-03-31 | -$6.96K 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $5.33K derived: sum of 2 quarters · filed 2020-11-16 | -$6.96K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $5.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$6.96K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | -$12.30K 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $6.96K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |